Bide Pharmatech (688073.SH) shareholders plan to reduce their holdings by a total of no more than 3%.
Bidder Medical (688073.SH) announced that due to its own funding needs, Ms. Dai Lan, Mr. Dai Long, Nanxu Investment, and Lanyun Wanchi plan to reduce their holdings by a total of no more than 3% of shares through centralized bidding and block trading, within three months following the disclosure date of this reduction plan, starting from 15 trading days thereafter, depending on market conditions.
Bide Pharmatech (688073.SH) announced that due to its own funding needs, Ms. Dai Lan, Mr. Dai Long, Nan Xu Investment, and Lanyun Wanchi plan to reduce their holdings by a total of no more than 3% of shares through centralized bidding and block trading within three months starting from the 15th trading day after the disclosure of this reduction plan, depending on market conditions.
Related Articles

MAANSHAN IRON (00323) recommends the election of the company's 11th Board of Directors.

DL HOLDINGS GP (01709) granted a total of 42 million shares as reward shares.

SAINT BELLA GP (02508) repurchased 20,000 shares for HKD 59,600 on September 9.
MAANSHAN IRON (00323) recommends the election of the company's 11th Board of Directors.

DL HOLDINGS GP (01709) granted a total of 42 million shares as reward shares.

SAINT BELLA GP (02508) repurchased 20,000 shares for HKD 59,600 on September 9.

RECOMMEND





